Exploring clustering of leprosy in the Comoros and Madagascar: A geospatial analysis.


Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
Jul 2021
Historique:
received: 19 03 2021
revised: 30 04 2021
accepted: 07 05 2021
pubmed: 16 5 2021
medline: 20 8 2021
entrez: 15 5 2021
Statut: ppublish

Résumé

To identify patterns of spatial clustering of leprosy. We performed a baseline survey for a trial on post-exposure prophylaxis for leprosy in Comoros and Madagascar. We screened 64 villages, door-to-door, and recorded results of screening, demographic data and geographic coordinates. To identify clusters, we fitted a purely spatial Poisson model using Kulldorff's spatial scan statistic. We used a regular Poisson model to assess the risk of contracting leprosy at the individual level as a function of distance to the nearest known leprosy patient. We identified 455 leprosy patients; 200 (44.0%) belonged to 2735 households included in a cluster. Thirty-eight percent of leprosy patients versus 10% of the total population live ≤25 m from another leprosy patient. Risk ratios for being diagnosed with leprosy were 7.3, 2.4, 1.8, 1.4 and 1.7, for those at the same household, at 1-<25 m, 25-<50 m, 50-<75 m and 75-<100 m as/from a leprosy patient, respectively, compared to those living at ≥100 m. We documented significant clustering of leprosy beyond household level, although 56% of cases were not part of a cluster. Control measures need to be extended beyond the household, and social networks should be further explored.

Identifiants

pubmed: 33991682
pii: S1201-9712(21)00415-X
doi: 10.1016/j.ijid.2021.05.014
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

96-101

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Auteurs

Nimer Ortuño-Gutiérrez (N)

Damien Foundation, Brussels, Belgium. Electronic address: Nimer.OrtunoGutierrez@damiaanactie.be.

Aboubacar Mzembaba (A)

National Tuberculosis and Leprosy Control Program, Moroni, Comoros.

Stéphanie Ramboarina (S)

Raoul Follereau Foundation, Antananarivo, Madagascar.

Randrianantoandro Andriamira (R)

National Leprosy Control Program, Antananarivo, Madagascar.

Abdallah Baco (A)

National Tuberculosis and Leprosy Control Program, Moroni, Comoros.

Sofie Braet (S)

Institute of Tropical Medicine, Antwerp, Belgium.

Assoumani Younoussa (A)

National Tuberculosis and Leprosy Control Program, Moroni, Comoros.

Bertrand Cauchoix (B)

Raoul Follereau Foundation, Antananarivo, Madagascar.

Zahara Salim (Z)

National Tuberculosis and Leprosy Control Program, Moroni, Comoros.

Mohamed Amidy (M)

National Tuberculosis and Leprosy Control Program, Moroni, Comoros.

Saverio Grillone (S)

National Tuberculosis and Leprosy Control Program, Moroni, Comoros.

Tahinamandranto Rasamoelina (T)

Centre d'Infectiologie Charles Mérieux, Université d'Antananarivo, Antananarivo, Madagascar.

Emmanuelle Cambau (E)

INSERM, IAME UMR1137, Université de Paris, 75018 Paris, France; APHP GHU Nord, Service de Mycocactériologie spécialisée et de référence, Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux - Laboratoire Associé, Paris, France.

Annemieke Geluk (A)

Leiden University Medical Center (LUMC), Department of Infectious Diseases, Leiden, The Netherlands.

Bouke C de Jong (BC)

Institute of Tropical Medicine, Antwerp, Belgium.

Jan Hendrik Richardus (JH)

Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Epco Hasker (E)

Institute of Tropical Medicine, Antwerp, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH